GHO appoints Miller, Hamilton-Fairley as operating partners

Both will support deal origination as well as GHO's portfolio companies.

Miller was formerly senior vice-president of global market access at Biogen with responsibility for the global pricing, reimbursement and access of Biogen's product portfolio, before founding his own advisory practice whose clients have included biotechnology firms of all sizes.

Hamilton-Fairley's experience includes developing and guiding Oncimmune, a company focused on early cancer detection, from a Nottingham University startup through to IPO in May 2016.

The firm is currently investing from GHO Capital II, which closed on €975m in November 2019.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• UK / Ireland
• GPs
• United Kingdom